Thyroid Cancer Cell Resistance to Gefitinib Depends on the Constitutive Oncogenic Activation of the ERK Pathway
- Type
- Retraction
- Notice date
- 2/28/2023 0:00
- Journal
- The Journal of Clinical Endocrinology and Metabolism
- Publisher
- Oxford University Press
- Notice DOI
- 10.1210/clinem/dgad056
- Original paper DOI
- 10.1210/jc.2012-3623